For much of the twentieth century, an epilepsy diagnosis could affect access to life insurance, accident cover and other forms of financial protection. Insurers often treated epilepsy as a marker of increased mortality or injury risk, sometimes without distinguishing between very different seizure patterns, causes or levels of control.
Risk tables came before personalised medicine
Insurance developed around population-level risk. Earlier underwriting practices frequently relied on broad diagnostic categories because detailed information about seizure type, treatment response, imaging and recurrence risk was limited. That could translate into higher premiums, exclusions or refusal of cover.
Why epilepsy was treated differently
Historically, insurers were concerned about premature death, accidents, drowning, occupational hazards and the possibility that seizures reflected serious underlying disease. The problem was that one label — epilepsy — covered people with very different prognoses.
Evidence gradually changed the picture
As long-term cohort studies improved estimates of mortality and seizure recurrence, underwriting could become more differentiated. Better treatment, clearer classification and modern diagnostics also made it possible to separate some higher-risk situations from people with long periods of seizure freedom or lower-risk epilepsy syndromes.
The wider social history
Insurance restrictions belong to the same historical pattern as employment barriers, marriage restrictions and immigration exclusions. Epilepsy could affect not only health care, but whether a person could obtain financial security, protect a mortgage or provide for family members.
Why this matters now
Modern insurance law and underwriting differ between countries, and many jurisdictions now regulate disability discrimination. But the history helps explain why people with epilepsy have often encountered questions about disclosure, eligibility and risk far beyond the clinic.
Sources and further reading
Mortality and prognosis in epilepsy — review
Mortality in epilepsy — population evidence
ILAE — epilepsy and society
Historical overview. Present-day insurance rules vary by country, product and individual circumstances.